Risk factors associated with breast arterial calcifications


Ilica A. T., AYDOĞAN Ü., Guvenc I., Cayci T., Oren C., Onar T., ...Daha Fazla

Acta Radiologica, cilt.52, sa.7, ss.702-705, 2011 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 7
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1258/ar.2011.110034
  • Dergi Adı: Acta Radiologica
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.702-705
  • Anahtar Kelimeler: Breast arterial calcification, mammography, hyperglycemia, blood urea nitrogen, creatinine
  • Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Background: A number of studies have linked the presence of breast arterial calcifications (BACs) with an increased risk of diabetes, hypertension, coronary artery disease (CAD), and cardiovascular mortality. Because there is a well-established screening system for breast cancer, it has been proposed that the presence of BACs can be used as a warning sign indicating an increased risk of metabolic and vascular diseases. Purpose: To determine the relation between BAC and early renal dysfunction. Material and Methods: A retrospective review of 6118 mammograms identified 701 cases with BACs. Women with BACs were compared to a random selection of 362 women without BACs based on available laboratory data. Univariate analysis was conducted according to age groups. Results: The prevalence of BACs was 11.5% in our study. Hyperglycemia increased the odds of BACs by 8.1 (95% CI 3.0-22.1, P < 0.001) in the 50-59-year age group. The presence of an elevated blood urea nitrogen (BUN) and serum creatinine increased the odds of BACs by 2.6 (95% CI1.2-6.0, P = 0.016) and 2.3 (95% CI 1.0-5.2, P = 0.045) in women ≥70 years of age. Hyperlipidemia was not a significant risk factor for BACs in any age group. Conclusion: Our results support the view that the presence of BACs on mammography may be indicative of diabetes in middle-aged women. On the other hand, BACs are not very useful for predicting early renal dysfunction in women <70 years of age.